In:
International Journal of Cancer, Wiley, Vol. 141, No. 5 ( 2017-09), p. 905-915
Abstract:
What's new? Pancreatic cancer has the worst prognosis of all cancers because of late detection, and early noninvasive biomarkers are urgently needed to improve outcome. Here, the authors examined blood levels of a panel of microRNAs previously associated with pancreatic cancer. Samples collected within two years of a cancer diagnosis showed elevated plasma levels of miR‐10b, miR‐21‐5p, miR‐30c and miR‐106b. In multivariable models, three of these microRNAs (10b, 21‐5p, 30c) as well as miR‐10a showed significant associations with subsequent risk underscoring the clinical potential of plasma microRNAs in pancreatic cancer screening.
Type of Medium:
Online Resource
ISSN:
0020-7136
,
1097-0215
Language:
English
Publisher:
Wiley
Publication Date:
2017
detail.hit.zdb_id:
218257-9
detail.hit.zdb_id:
1474822-8
Permalink